[1]Jemal A,Siegel R,Ward E,et al.Cancer statistics,2007[J].CA Cancer J Clin,2007,57(1):43-66.
[2]Yuan K,Xie K,Fox J,et al.Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2,suppressing maspin and promoting colorectal tumor growth and metastasis in mice[J].Gastroenterology,2013,145(4):853-864.
[3]Arndt GM,Dossey L,Cullen LM,et al.Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer[J].BMC Cancer,2009,9(1):374-390.
[4]González-Sarrías A,Núez-Sánchez M,Tomé-Carneiro J,et al.Comprehensive characterization of the effects of ellagic acid and urolithins on colorectal cancer and key-associated molecular hallmarks:MicroRNA cell specific induction of CDKN1A(p21)as a common mechanism involved[J].Mol Nutr Food Res,2016,60(4):701-716.
[5]YANG Guanglei.The molecular mechanism of chemotherapy resistance and anti-apoptosis in humancolon cancer cell under simulated hypoxia[D].Hebei:The Medical University of Hebei,2009.[杨光磊.模拟缺氧条件下结肠癌细胞耐药及抗凋亡分子机制研究[D].河北:河北医科大学,2009.]
[6]Shubham S,Robert S,Ranjit R,et al.MicroRNAs:Role in hepatitis C virus pathogenesis[J].Genes Dis,2015,2(1):35-45.
[7]Min S,Jiujie C,Keping X.Signaling of MiRNAs-FOXM1 in cancer and potential targeted therapy[J].Curr Drug Targets,2013,14(10):1192-1202.
[8]Tatekoshi Y,Tanno M,Kouzu H,et al.Translational regulation by miR-301b upregulates AMP deaminase in diabetic hearts[J].J Mol Cell Cardiol,2018(119):138-146.
[9]Zhong X,Li P,Li J,et al.Downregulation of microRNA-34a inhibits oxidized low density lipoprotein induced apoptosis and oxidative stress in human umbilical vein endothelial cells[J].Int J Mol Med,2018,42(2):1134-1144.
[10]Bartal DP.MicroRNAs:Genomics,biogenesis,mechanism,323 and function[J].Cell,2014(116):281-297.
[11]Schetter AJ,Okayama H,Harris CC.The role of microRNAs 325 in colorectal cancer[J].Cancer Journal,2012,18(3):244-252.
[12]Corte H,Manceau G,Blons H,et al.MicroRNA and colorectal cancer[J].Digestive and Liver Disease,2012,44(3):195-200.
[13]Link A,Goel A.MicroRNA in gastrointestinal cancer:a step closer to reality[J].Advances in Clinical Chemistry,2013,62(4):221-268.
[14]Ke TW,Hsu HL,Wu YH,et al.MicroRNA-224 suppresses colorectal cancer cell migration 334 by targeting Cdc42[J].Disease Markers,2014(2014):617150.
[15]Zhu Y,Xu A,Li J,et al.Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer[J].Cancer Biomark,2016,16(2):259-264.
[16]YU Weifang,FAN Zhibin,ZHANG Xueming,et al.MicroRNA-224 expression in colon cancer cells and its significance[J].Chinese Journal of General Surgery,2014,23(4):478-482.[于卫芳,樊智彬,张学明,等.microRNA-224在结肠癌细胞中的表达及意义[J].中国普通外科杂志,2014,23(4):478-482.]
[17]Siegel RL,Miller KD,Fedewa SA,et al.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(3):177-193.
[18]WANG Wentao,FENG Yong.Laparoscopic versus open surgery for complete mesocolic excision with colon cancer:A Meta-analysis[J].Chinese Journal of Practical Surgery,2015,35(1):79-85,103.[王文韬,冯勇.腹腔镜与开腹结肠癌完整结肠系膜切除术比较Meta分析[J].中国实用外科杂志,2015,35(1):79-85,103.]
[19]Zhang Y,Guo CC,Guan DH,et al.Prognostic value of microRNA-224 in various cancers:A Meta-analysis[J].Arch Med Res,2017,48(5):472-482.
[20]Wan Y,Zeng ZC,Xi M,et al.Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer[J].Hum Pathol,2015,46(2):295-303.
[21]Fu J,Tang W,Du P,et al.Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis[J].BMC Syst Biol,2015,36(6):4525-4534.
[22]Lau NC,Lim LP,Weinstein EG,et al.An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans[J].Science,2001(294):858-862.
[23]Lee RC,Ambros V.An extensive class of small RNAs in Caenorhabditis elegans[J].Science,2001,294(5543):862-864.
[24]Farazi TA,Hoell JI,Morozov P,et al.MicroRNAs in human cancer[J].Adv Exp Med Biol,2013(774):1-20.
[25]Toiyama Y,Tanaka K,Inoue Y,et al.Circulating cell-free microRNAs as biomarkers for colorectal cancer[J].Surg Today,2016(46):13-24.
[26]Fougerolles A,Vornlocher HP,Maraganore J,et al.Interfering with disease:a progress report on siRNA-based therapeutics[J].Nat Rev Drug Discov,2007(6):443-453.